Pages that link to "Q44304574"

The following pages link to Structure-based de novo design, synthesis, and biological evaluation of non-azole inhibitors specific for lanosterol 14alpha-demethylase of fungi (Q44304574):

Displaying 31 items.

• Minimal Pharmacophoric Elements and Fragment Hopping, an Approach Directed at Molecular Diversity and Isozyme Selectivity. Design of Selective Neuronal Nitric Oxide Synthase Inhibitors (Q27649995) (← links)
• X-ray Structure of 4,4'-Dihydroxybenzophenone Mimicking Sterol Substrate in the Active Site of Sterol 14 -Demethylase (CYP51) (Q27650159) (← links)
• The multi-copy simultaneous search methodology: a fundamental tool for structure-based drug design (Q33464348) (← links)
• 2-Amino-nonyl-6-methoxyl-tetralin muriate inhibits sterol C-14 reductase in the ergosterol biosynthetic pathway (Q33556437) (← links)
• Fragment-Based Approaches and Computer-Aided Drug Discovery (Q33944493) (← links)
• Synthesis, structure-activity relationship studies, and antibacterial evaluation of 4-chromanones and chalcones, as well as olympicin A and derivatives (Q34394121) (← links)
• Computer-based de novo design of drug-like molecules (Q34438895) (← links)
• Drug strategies targeting CYP51 in neglected tropical diseases (Q34622554) (← links)
• An update on antifungal targets and mechanisms of resistance in Candida albicans (Q36235037) (← links)
• Cloning and characterization of CYP51 from Mycobacterium avium (Q37098577) (← links)
• Three-dimensional model of lanosterol 14 alpha-demethylase from Cryptococcus neoformans: active-site characterization and insights into azole binding (Q37274762) (← links)
• Triazole derivatives with improved in vitro antifungal activity over azole drugs (Q37701941) (← links)
• Fragment informatics and computational fragment-based drug design: an overview and update (Q37995087) (← links)
• Dual-action hypoglycemic and hypocholesterolemic agents that inhibit glycogen phosphorylase and lanosterol demethylase (Q38333023) (← links)
• Effect of novel triazole-amino acid hybrids on growth and virulence of Candida species: in vitro and in vivo studies (Q38741369) (← links)
• Antimicrobial/Antibiofilm Activity and Cytotoxic Studies of β-Thujaplicin Derivatives. (Q38758823) (← links)
• Strategies in the discovery of novel antifungal scaffolds (Q38837363) (← links)
• Designing the molecular future (Q39681302) (← links)
• Structure‐Based Design, Synthesis, and Antifungal Activity of New Triazole Derivatives (Q42735722) (← links)
• Novel conformationally restricted triazole derivatives with potent antifungal activity (Q42857169) (← links)
• Synthesis and in vitro antifungal activities of new 3-substituted benzopyrone derivatives (Q42858761) (← links)
• Improved model of lanosterol 14alpha-demethylase by ligand-supported homology modeling: validation by virtual screening and azole optimization (Q43161102) (← links)
• Synthesis, antifungal activity, and docking study of some new 1,2,4-triazole analogs. (Q45394429) (← links)
• Imidazolylchromanones containing alkyl side chain as lanosterol 14α-demethylase inhibitors: synthesis, antifungal activity and docking study. (Q45894478) (← links)
• Molecular design of two sterol 14alpha-demethylase homology models and their interactions with the azole antifungals ketoconazole and bifonazole (Q46628863) (← links)
• Molecular dynamic modeling of CYP51B in complex with azole inhibitors (Q51002022) (← links)
• Evolutionary trace analysis of CYP51 family: implication for site-directed mutagenesis and novel antifungal drug design (Q56897153) (← links)
• Combining ligand-based and structure-based drug design in the virtual screening arena (Q56979676) (← links)
• Antifungal activities of novel non-azole molecules against S. cerevisiae and C. albicans (Q82593376) (← links)
• Design and synthesis of antifungal benzoheterocyclic derivatives by scaffold hopping (Q83630630) (← links)
• Design and synthesis of novel triazole antifungal derivatives by structure-based bioisosterism (Q85064946) (← links)